SUMMARY AND CONCLUSIONS
In this brief overview we have tried to capture the excitement spawning from the rise of a new
understanding of epigenetic molecular mechanisms and their relevance to CNS function and
dysfunction. We consider this review to be a snapshot of where things stand at this point in time,
with emerging new epigenetic mechanisms and targets surely to be over the horizon. The extent
to which pharmacology will be able to capitalize on epigenetic processes and their regulation
of the brain is certainly not yet clear. Nevertheless, the idiosyncratic power and properties of
epigenetic mechanisms, and the unique pharmacology they may allow, hold great promise for
future development.